A new study published in the NPJ Primary Care Respiratory Medicine journal revealed that home spirometry significantly improved and expedited asthma diagnosis, with nearly 80% of patients ...

A simple 3-biomarker score meaningfully improves risk stratification for both prevalent and incident rheumatoid arthritis (RA)-associated interstitial lung disease (ILD), supporting a targeted, ...

As the limitations of manual culturing and visual inspection become more apparent, the industry is shifting toward passive ...

Titled “Simultaneous prenatal cfDNA screening of aneuploidy, recessive single-gene conditions, and fetomaternal blood compatibility,” the study used nearly 500 samples to assess the multiple ...

Background and objectives Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and effective treatment.

CDNA shares climb after AlloHeme data show early AML/MDS relapse detection, backing its Transplant+ expansion into cell ...

A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...

The researchers suggest that this improvement in diagnostic performance for OFC biomarker discovery can be used to develop a diagnostic alternative for food allergy that is scalable and more efficient ...

Median’s eyonis LCS is being evaluated as a tool to help assess the likelihood that a lung lesion detected on low-dose CT is malignant, Oran Muduroglu, founder and CEO of Coeus Health, said in an ...

Creative Biolabs, a global leader in antibody engineering, today announced its optimization of ADCC and Fc-mediated ...

The successful clinical validation of AlloHeme represents a key milestone in CareDx's Transplant+ strategy, expanding the Company's precision medicine capabilities into cell therapy, hematology, and ...